Post-operative treatment for patients treated with SIOP 2001 protocol that had immediate operation.

Table 3: Post-operative treatment for patients treated with SIOP 2001 protocol that had immediate operation.

Patients	Treatment regimen
Stage I, intermediate risk (exclude focal anaplasia)	1: 10 weeks of Vincristine
Stage I focal anaplasia Stage II, Low and intermediate risks	2: 26 weeks with Vincristine and Actinomycin D
Stage III, IR (include focal anaplasia)	3: 28 weeks with Vincristine, Actinomycin D, Doxorubicin and Radiotherapy
Stage I-IV High risk	As for patients with preoperative chemotherapy